Skip to content
MedsAcross

Fixed-dose combination

Brompheniramine, Dextromethorphan and Pseudoephedrine

Also known as brompheniramine maleate, dextromethorphan hydrobromide, pseudoephedrine hydrochloride
Available on request
Presentations
2
Brands
0
Manufacturers
0
Available from stock
0

Brompheniramine, Dextromethorphan and Pseudoephedrine is a fixed-dose combination of a sigma-1 agonist, an uncompetitive N-methyl-D-aspartate receptor antagonist and an alpha-adrenergic agonist. It is available as syrup and oral solution. MedsAcross supplies Brompheniramine, Dextromethorphan and Pseudoephedrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Alpha-Adrenergic Agonist, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Adrenergic alpha-Agonists, Sigma-1 Receptor Agonists, Uncompetitive NMDA Receptor Antagonists
US FDA first approval
24 August 1984
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Oral
Dosage forms
Syrup, Oral solution
Fixed-dose combination of
Brompheniramine, Dextromethorphan, Pseudoephedrine
Identifiers
RxCUI 690808Q48566716

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

For relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.

Source: US FDA prescribing information

Dosing overview

Adults and pediatric patients 12 years of age and over: 10 mL (2 teaspoonfuls) every 4 hours. Children 6 to under 12 years of age: 5 mL (1 teaspoonful) every 4 hours. Children 2 to under 6 years of age: 2.5 mL (½ teaspoonful) every 4 hours. Infants 6 months to under 2 years of age: Dosage to be established by a physician. Do not exceed 6 doses during a 24-hour period.

Source: US FDA prescribing information

Contraindications

Hypersensitivity to any of the ingredients. Do not use in the newborn, in premature infants, in nursing mothers, or in patients with severe hypertension or severe coronary artery disease. Do not use dextromethorphan in patients receiving monoamine oxidase (MAOI) inhibitors. Antihistamines should not be used to treat lower respiratory tract conditions including asthma.

Source: US FDA prescribing information

Warnings and precautions

Especially in infants and small children, antihistamines in overdosage may cause hallucinations, convulsions, and death. Antihistamines may diminish mental alertness. In the young child, they may produce excitation.

Source: US FDA prescribing information

Side effects

The most frequent adverse reactions to brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide syrup are: sedation, dryness of mouth, nose and throat, thickening of bronchial secretions, dizziness. Other adverse reactions may include: Dermatologic: Urticaria, drug rash, photosensitivity, pruritus. Cardiovascular System: Hypotension, hypertension, cardiac arrhythmias, palpitation. CNS: Disturbed coordination, tremor, irritability, insomnia, visual disturbances, weakness, nervousness, convulsions, headache, euphoria, and dysphoria. G.U. System: Urinary frequency, difficult urination. G.I. System: Epigastric discomfort, anorexia, nausea, vomiting, diarrhea, constipation. Respiratory System: Tightness of chest and wheezing, shortness of breath. Hematologic System: Hemolytic anemia, thrombocytopenia, agranulocytosis.

Source: US FDA prescribing information

Interactions

Monoamine oxidase (MAO) inhibitors Hyperpyrexia, hypotension, and death have been reported coincident with the coadministration of MAO inhibitors and products containing dextromethorphan. In addition, MAO inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines and may enhance the effect of pseudoephedrine. Concomitant administration of brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide syrup and MAO inhibitors should be avoided. Central nervous system (CNS) depressants Antihistamines have additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, antianxiety agents, etc.). Antihypertensive drugs Sympathomimetic may reduce the effects of antihypertensive drugs.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

2 presentations of Brompheniramine, Dextromethorphan and Pseudoephedrine, sorted by availability.

MedicineActive ingredientManufacturerRegisterAvailability
Brompheniramine, Dextromethorphan and Pseudoephedrine 2 mg/10 mg/30 mg per 5 mL syrupOralGeneric nameBrompheniramine, Dextromethorphan and Pseudoephedrine—US FDAAvailable on request
Brompheniramine, Dextromethorphan and Pseudoephedrine 2 mg/10 mg/30 mg per 5 mL oral solutionOralGeneric nameBrompheniramine, Dextromethorphan and Pseudoephedrine—US FDAAvailable on request

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 24 August 1984Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Brompheniramine, Dextromethorphan and Pseudoephedrine available for export from India?

Yes, on request. MedsAcross lists 2 presentations of Brompheniramine, Dextromethorphan and Pseudoephedrine and sources them for licensed hospitals, importers and physicians against valid import documents.

Is Brompheniramine, Dextromethorphan and Pseudoephedrine approved by the US FDA?

Yes. The US FDA first approved Brompheniramine, Dextromethorphan and Pseudoephedrine on 24 August 1984, according to Drugs@FDA.

Does Brompheniramine, Dextromethorphan and Pseudoephedrine need cold chain shipping?

No listed presentation of Brompheniramine, Dextromethorphan and Pseudoephedrine is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

References

  1. Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide prescribing information (Dr. Reddy's Laboratories). U.S. National Library of Medicine, DailyMed. Retrieved 22 June 2026

Request Brompheniramine, Dextromethorphan and Pseudoephedrine for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.